Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 7/12/2018 |
| Start Date: | February 2009 |
| End Date: | January 2012 |
The Effect of Intracameral Triesence (Triamcinolone Acetonide Injectable Suspension) on Ocular Inflammation After Trabeculectomy, Tube Shunt Implantation or Combined Trabeculectomy With Cataract Surgery
The investigators hypothesize that intracameral Triesence during glaucoma surgery will
provide lower intraocular pressure through better control of ocular inflammation, thus
leading to a more successful filtering procedure.
provide lower intraocular pressure through better control of ocular inflammation, thus
leading to a more successful filtering procedure.
Determine the efficacy and safety of intracameral Triesence in patients who undergo
trabeculectomy, tube shunt, or combined cataract extraction, intra-ocular lens implantation
and trabeculectomy with or without adjunctive mitomycin-C.
trabeculectomy, tube shunt, or combined cataract extraction, intra-ocular lens implantation
and trabeculectomy with or without adjunctive mitomycin-C.
Inclusion Criteria:
- glaucoma patients requiring surgery (Trabeculectomy or Express Shunt; Trabeculectomy
plus Phacoemulsification and Interocular Lens Implant; Baerveldt Tube; Ahmed Tube;
Molteno Tube)
- primary open angle glaucoma
- primary angle-closure glaucoma
- pseudoexfoliation glaucoma
- pigmentary glaucoma
- traumatic glaucoma
- neovascular glaucoma
Exclusion Criteria:
- patients that are pregnant, nursing, or not using adequate contraception
- any other eye surgery except cataract surgery
- an infection, inflammation, or any abnormality preventing measurement of eye pressure
- enrolled in another investigational study
We found this trial at
1
site
Click here to add this to my saved trials
